Publikation

Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States.

Wissenschaftlicher Artikel/Review - 01.09.2022

Bereiche
PubMed
DOI
Kontakt

Zitation
Patel K, Huo Y, Jao J, Powis K, Williams P, Kacanek D, Yee L, Chadwick E, Shiau S, Jacobson D, Brummel S, Sultan-Beyer L, Kahlert C, Zash R, Seage G, ĀăąĆĉČĎ Ā. Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States. N Engl J Med 2022; 387:799-809.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
N Engl J Med 2022; 387
Veröffentlichungsdatum
01.09.2022
eISSN (Online)
1533-4406
Seiten
799-809
Kurzbeschreibung/Zielsetzung

Data on the effectiveness and safety of dolutegravir-based antiretroviral therapy (ART) for human immunodeficiency virus type 1 (HIV-1) infection in pregnancy as compared with other ART regimens commonly used in the United States and Europe, particularly when initiated before conception, are limited.